Therapeutic Protein–Drug Interactions and Implications for Drug Development
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Protein–Drug Interactions and Implications for Drug Development
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 87, Issue 4, Pages 497-503
Publisher
Springer Nature
Online
2010-03-04
DOI
10.1038/clpt.2009.308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transporters in drug development: advancing on the Critical Path
- (2010) Shiew-Mei Huang et al. NATURE REVIEWS DRUG DISCOVERY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Drug interactions evaluation: An integrated part of risk assessment of therapeutics
- (2010) Lei Zhang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Predicting Drug–Drug Interactions: An FDA Perspective
- (2009) Lei Zhang et al. AAPS Journal
- Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
- (2009) Crystal S. Denlinger et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective
- (2009) S-M Huang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics
- (2009) ET Morgan CLINICAL PHARMACOLOGY & THERAPEUTICS
- The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
- (2009) S-M Huang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Scientific and Regulatory Perspectives on Metabolizing Enzyme−Transporter Interplay and Its Role in Drug Interactions: Challenges in Predicting Drug Interactions†
- (2009) Lei Zhang et al. MOLECULAR PHARMACEUTICS
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
- (2008) Y Zhang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice
- (2008) S-M Huang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor- or Interleukin-6
- (2008) M. L. Vee et al. DRUG METABOLISM AND DISPOSITION
- Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
- (2008) E. T. Morgan et al. DRUG METABOLISM AND DISPOSITION
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
- (2008) Shiew-Mei Huang et al. JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now